ITRM

Iterum Therapeutics (ITRM)

About Iterum Therapeutics (ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

Details

Daily high
$0.43
Daily low
$0.40
Price at open
$0.42
52 Week High
$2.10
52 Week Low
$0.36
Market cap
22.2M
Dividend yield
0.00%
Volume
9,111
Avg. volume
1.1M
P/E ratio
-.56

Iterum Therapeutics News

Details

Daily high
$0.43
Daily low
$0.40
Price at open
$0.42
52 Week High
$2.10
52 Week Low
$0.36
Market cap
22.2M
Dividend yield
0.00%
Volume
9,111
Avg. volume
1.1M
P/E ratio
-.56